You just read:

Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes

News provided by

Synthetic Biologics, Inc.

Dec 07, 2013, 01:30 ET